 | • レポートコード：QYR9NV01583 • 出版社/出版日：QYResearch / 2019年11月12日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥525,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,050,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、B細胞慢性リンパ性白血病の治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AMG-319、ATTCK-20、IDD-002、JNJ-64052781、レナリドマイド、MAT-303、MT-3724、その他に、用途別には、クリニック、病院、その他にセグメント区分し、B細胞慢性リンパ性白血病の治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・B細胞慢性リンパ性白血病の治療の世界市場概要 ・B細胞慢性リンパ性白血病の治療の製造コスト構成分析 ・B細胞慢性リンパ性白血病の治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・B細胞慢性リンパ性白血病の治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・B細胞慢性リンパ性白血病の治療のセグメント分析（種類別） （AMG-319、ATTCK-20、IDD-002、JNJ-64052781、レナリドマイド、MAT-303、MT-3724、その他） ・B細胞慢性リンパ性白血病の治療のセグメント分析（用途別） （クリニック、病院、その他） ・B細胞慢性リンパ性白血病の治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （AB Science SA、Amgen Inc.、Celgene Corporation、Dynavax Technologies Corporation、Eisai、Elsalys Biotech SAS、F. Hoffmann-La Roche Ltd.、iDD biotech SAS、Immunomedics, Inc.、Johnson & Johnson、Juno Therapeutics Inc.、Molecular Templates Inc.、Noxxon Pharma AG、） ・B細胞慢性リンパ性白血病の治療の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global B-Cell Chronic Lymphocytic Leukemia Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on B-Cell Chronic Lymphocytic Leukemia Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall B-Cell Chronic Lymphocytic Leukemia Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of B-Cell Chronic Lymphocytic Leukemia Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their B-Cell Chronic Lymphocytic Leukemia Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AB Science SA
Amgen Inc.
Celgene Corporation
Dynavax Technologies Corporation
Eisai
Elsalys Biotech SAS
F. Hoffmann-La Roche Ltd.
iDD biotech SAS
Immunomedics, Inc.
Johnson & Johnson
Juno Therapeutics Inc.
Molecular Templates Inc.
Noxxon Pharma AG
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
AMG-319
ATTCK-20
IDD-002
JNJ-64052781
Lenalidomide
MAT-303
MT-3724
Others
Segment by Application
Clinic
Hospital
Others
Table of Contents
Executive Summary
1 Industry Overview of B-Cell Chronic Lymphocytic Leukemia Treatment
1.1 Definition of B-Cell Chronic Lymphocytic Leukemia Treatment
1.2 B-Cell Chronic Lymphocytic Leukemia Treatment Segment by Type
1.2.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 AMG-319
1.2.3 ATTCK-20
1.2.4 IDD-002
1.2.5 JNJ-64052781
1.2.6 Lenalidomide
1.2.7 MAT-303
1.2.8 MT-3724
1.2.9 Others
1.3 B-Cell Chronic Lymphocytic Leukemia Treatment Segment by Applications
1.3.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global B-Cell Chronic Lymphocytic Leukemia Treatment Overall Market
1.4.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (2014-2025)
1.4.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Production (2014-2025)
1.4.3 North America B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)
1.4.4 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)
1.4.5 China B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)
1.4.6 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)
1.4.8 India B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment
2.3 Manufacturing Process Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment
2.4 Industry Chain Structure of B-Cell Chronic Lymphocytic Leukemia Treatment
3 Development and Manufacturing Plants Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment
3.1 Capacity and Commercial Production Date
3.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of B-Cell Chronic Lymphocytic Leukemia Treatment
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 B-Cell Chronic Lymphocytic Leukemia Treatment Production and Capacity Analysis
4.2 B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Analysis
4.3 B-Cell Chronic Lymphocytic Leukemia Treatment Price Analysis
4.4 Market Concentration Degree
5 B-Cell Chronic Lymphocytic Leukemia Treatment Regional Market Analysis
5.1 B-Cell Chronic Lymphocytic Leukemia Treatment Production by Regions
5.1.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Production by Regions
5.1.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Regions
5.2 B-Cell Chronic Lymphocytic Leukemia Treatment Consumption by Regions
5.3 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
5.3.1 North America B-Cell Chronic Lymphocytic Leukemia Treatment Production
5.3.2 North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export
5.4 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
5.4.1 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Production
5.4.2 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export
5.5 China B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
5.5.1 China B-Cell Chronic Lymphocytic Leukemia Treatment Production
5.5.2 China B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export
5.6 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
5.6.1 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Production
5.6.2 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export
5.7 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
5.7.1 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Production
5.7.2 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export
5.8 India B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
5.8.1 India B-Cell Chronic Lymphocytic Leukemia Treatment Production
5.8.2 India B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export
6 B-Cell Chronic Lymphocytic Leukemia Treatment Segment Market Analysis (by Type)
6.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Production by Type
6.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Type
6.3 B-Cell Chronic Lymphocytic Leukemia Treatment Price by Type
7 B-Cell Chronic Lymphocytic Leukemia Treatment Segment Market Analysis (by Application)
7.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption by Application
7.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Market Share by Application (2014-2019)
8 B-Cell Chronic Lymphocytic Leukemia Treatment Major Manufacturers Analysis
8.1 AB Science SA
8.1.1 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.1.2 AB Science SA Product Introduction, Application and Specification
8.1.3 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Amgen Inc.
8.2.1 Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.2.2 Amgen Inc. Product Introduction, Application and Specification
8.2.3 Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Celgene Corporation
8.3.1 Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.3.2 Celgene Corporation Product Introduction, Application and Specification
8.3.3 Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Dynavax Technologies Corporation
8.4.1 Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.4.2 Dynavax Technologies Corporation Product Introduction, Application and Specification
8.4.3 Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Eisai
8.5.1 Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.5.2 Eisai Product Introduction, Application and Specification
8.5.3 Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Elsalys Biotech SAS
8.6.1 Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.6.2 Elsalys Biotech SAS Product Introduction, Application and Specification
8.6.3 Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 F. Hoffmann-La Roche Ltd.
8.7.1 F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.7.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
8.7.3 F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 iDD biotech SAS
8.8.1 iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.8.2 iDD biotech SAS Product Introduction, Application and Specification
8.8.3 iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Immunomedics, Inc.
8.9.1 Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.9.2 Immunomedics, Inc. Product Introduction, Application and Specification
8.9.3 Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Johnson & Johnson
8.10.1 Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.10.2 Johnson & Johnson Product Introduction, Application and Specification
8.10.3 Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Juno Therapeutics Inc.
8.12 Molecular Templates Inc.
8.13 Noxxon Pharma AG
9 Development Trend of Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment Market
9.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Trend Analysis
9.1.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 B-Cell Chronic Lymphocytic Leukemia Treatment Regional Market Trend
9.2.1 North America B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
9.2.2 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
9.2.3 China B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
9.2.4 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
9.2.5 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
9.2.6 India B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
9.3 B-Cell Chronic Lymphocytic Leukemia Treatment Market Trend (Product Type)
9.4 B-Cell Chronic Lymphocytic Leukemia Treatment Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 B-Cell Chronic Lymphocytic Leukemia Treatment Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of B-Cell Chronic Lymphocytic Leukemia Treatment
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share by Types in 2018
Figure AMG-319 Product Picture
Figure ATTCK-20 Product Picture
Figure IDD-002 Product Picture
Figure JNJ-64052781 Product Picture
Figure Lenalidomide Product Picture
Figure MAT-303 Product Picture
Figure MT-3724 Product Picture
Figure Others Product Picture
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) (2014-2025)
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs) (2014-2025)
Figure North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Million USD) (2014-2025)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Million USD) (2014-2025)
Figure China B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Million USD) (2014-2025)
Figure Japan B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Million USD) (2014-2025)
Figure India B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Million USD) (2014-2025)
Table B-Cell Chronic Lymphocytic Leukemia Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment in 2018
Figure Manufacturing Process Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment
Figure Industry Chain Structure of B-Cell Chronic Lymphocytic Leukemia Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Manufacturing Plants Distribution
Table B-Cell Chronic Lymphocytic Leukemia Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table B-Cell Chronic Lymphocytic Leukemia Treatment Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs) of Major Manufacturers (2014-2019)
Table B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure B-Cell Chronic Lymphocytic Leukemia Treatment Production Share by Manufacturers in 2018
Table B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Share by Manufacturers in 2018
Table B-Cell Chronic Lymphocytic Leukemia Treatment Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Production by Regions 2014-2019 (K Pcs)
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share by Regions 2014-2019
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share by Regions in 2018
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Regions 2014-2019
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Regions in 2018
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption by Regions 2014-2019 (K Pcs)
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Market Share by Regions 2014-2019
Figure North America B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America B-Cell Chronic Lymphocytic Leukemia Treatment Production, Consumption Import and Export (K Pcs)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe B-Cell Chronic Lymphocytic Leukemia Treatment Production, Consumption Import and Export (K Pcs)
Figure China B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure China B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China B-Cell Chronic Lymphocytic Leukemia Treatment Production, Consumption Import and Export (K Pcs)
Figure Japan B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Japan B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan B-Cell Chronic Lymphocytic Leukemia Treatment Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Production, Consumption Import and Export (K Pcs)
Figure India B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure India B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India B-Cell Chronic Lymphocytic Leukemia Treatment Production, Consumption Import and Export (K Pcs)
Figure Global Consumption B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application (2014-2019)
Table AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of B-Cell Chronic Lymphocytic Leukemia Treatment by Type (2019-2025)
Table Global Consumption (K Pcs) of B-Cell Chronic Lymphocytic Leukemia Treatment by Application (2019-2025)
Table B-Cell Chronic Lymphocytic Leukemia Treatment Distributors List
Table B-Cell Chronic Lymphocytic Leukemia Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
B細胞リンパ腫2阻害剤のグローバル市場：規模・現状・予測2019-2025 Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis.The symptoms of hematological malignancies are often mild …- B細胞リンパ腫2阻害剤のグローバル市場：規模・現状・予測2019-2025 Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis.The symptoms of hematological malignancies are often mild …
- 慢性片頭痛治療のグローバル市場：規模・現状・予測2019-2025 Migraine is a painful, episodic disease that sometimes develops into a chronic condition. It is one of the most common neurological diseases in clinical practice. Chronic migraines (CM) are a natural progression of chronic migraines, with a frequency of 15 days per month and similar characteristics …
- 慢性片頭痛治療のグローバル市場：規模・現状・予測2019-2025 Migraine is a painful, episodic disease that sometimes develops into a chronic condition. It is one of the most common neurological diseases in clinical practice. Chronic migraines (CM) are a natural progression of chronic migraines, with a frequency of 15 days per month and similar characteristics …
- 世界の有毛細胞白血病治療産業調査2019-2025 Hairy cell leukemia is a slow-growing, rare type of chronic cell leukemia.In 2018, the global Hairy Cell Leukemia Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 20…